Ocular Immunology and Inflammation
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.7 | Q3 | 39.8% | 0.724 | Q2 | 74.0% |
| 2024 | 2.0 | Q2 | 56.1% | 0.805 | Q2 | 78.0% |
| 2023 | 2.6 | Q2 | 71.8% | 0.836 | Q2 | 81.0% |
| 2022 | 3.3 | Q2 | 77.4% | 0.805 | Q1 | 80.7% |
| 2021 | 3.7 | Q2 | 72.8% | 1.232 | Q1 | 90.4% |
| 2020 | — | — | 0.775 | Q2 | 79.0% | |
| 2019 | — | — | 0.780 | Q2 | 79.7% | |
| 2018 | — | — | 0.764 | Q2 | 77.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0927-3948
ISSN
1744-5078
country
GBcoverage
1993-2026